HomeOwner SearchCategory Search
Visit USCORational Targeting of BAX and BCL-XL Broadly Overcomes Tumor Apoptotic Resistance
Text Registration
Copyright Title
Rational Targeting of BAX and BCL-XL Broadly Overcomes Tumor Apoptotic Resistance
Status
Published
on 13 Jul 2021
Year of Creation
2020
Copyright Claimant
Andrea G. Lopez-Arroyo
Registration Number
TX0008988253
on 13 Jul 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008988253) dated 13 Jul 2021, pertains to an electronic file (eService) titled "Rational Targeting of BAX and BCL-XL Broadly Overcomes Tumor Apoptotic Resistance" created in 2020. The copyright holder is Andrea G. Lopez-Arroyo, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Andrea G. Lopez-Arroyo.
Application Details
Registration Number
TX0008988253
Registration Date
7/13/2021
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISBN
9798672113609
Statements
Application Title Statement: Rational Targeting of BAX and BCL-XL Broadly Overcomes Tumor Apoptotic Resistance
Author Statement: Andrea G. Lopez-Arroyo Domicile: United States Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.